TikkunLev Therapeutics brings together diverse talents with deep roots in biotechnology therapeutic development, gene therapy R&D, cardiology, and heart failure.
Director of the University of Utah’s Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI), and Presidential Endowed Chair and Professor of Medicine. Serial innovator in cardiovascular disease, discovering novel drug targets and gene therapies.
Co-Founder (retired) Bluepearl Pet Hospital, the largest network of veterinary specialty and emergency hospitals in the world with over 100 locations and 7,000 employees.
25 years experience in gene therapy and biologics R&D. Former Gene Therapy group leader and product reviewer at the FDA’s Division of Cell and Gene Therapy
35 years in the pharmaceutical and medical device R&D and commercialization. Led Business Development for Clinical Diagnostics at Janssen and former commercial leader at Novartis